These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6683113)

  • 1. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells.
    Loskutoff DJ; Mussoni L
    Blood; 1983 Jul; 62(1):62-8. PubMed ID: 6683113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
    Levin EG; Loskutoff DJ
    J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Habutobin releases plasminogen activator (U-PA) from bovine pulmonary artery endothelial cells.
    Sunagawa M; Hanashiro K; Nakamura M; Kosugi T
    Toxicon; 1996 Jun; 34(6):691-9. PubMed ID: 8817813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.
    Gurewich V; Pannell R
    Blood; 1987 Mar; 69(3):769-72. PubMed ID: 2949785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
    Cheng SL; Shen V; Peck WA
    Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
    Loskutoff DJ; van Mourik JA; Erickson LA; Lawrence D
    Proc Natl Acad Sci U S A; 1983 May; 80(10):2956-60. PubMed ID: 6574465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.
    Mimuro J; Schleef RR; Loskutoff DJ
    Blood; 1987 Sep; 70(3):721-8. PubMed ID: 3113515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
    J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
    van Mourik JA; Lawrence DA; Loskutoff DJ
    J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells.
    Van Hinsbergh VW; Sprengers ED; Kooistra T
    Thromb Haemost; 1987 Apr; 57(2):148-53. PubMed ID: 3496679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of plasminogen activator from bovine parathyroid cells.
    Bansal DD; MacGregor RR
    Endocrinology; 1990 May; 126(5):2245-51. PubMed ID: 2109681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC; Chang TS; Verderber E
    J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.